|
1
|
Carmichael SL: Birth defects epidemiology.
Eur J Med Genet. 57:355–358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hui L and Bianchi DW: Cell-free fetal
nucleic acids in amniotic fluid. Hum Reprod Update. 17:362–371.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Underwood MA, Gilbert WM and Sherman MP:
Amniotic fluid: Not just fetal urine anymore. J Perinatol.
25:341–348. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Da Sacco S, Sedrakyan S, Boldrin F,
Giuliani S, Parnigotto P, Habibian R, Warburton D, De Filippo RE
and Perin L: Human amniotic fluid as a potential new source of
organ specific precursor cells for future regenerative medicine
applications. J Urol. 183:1193–1200. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamath-Rayne BD, Smith HC, Muglia LJ and
Morrow AL: Amniotic fluid: The use of high-dimensional biology to
understand fetal well-being. Reprod Sci. 21:6–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Larrabee PB, Johnson KL, Lai C, Ordovas J,
Cowan JM, Tantravahi U and Bianchi DW: Global gene expression
analysis of the living human fetus using cell-free messenger RNA in
amniotic fluid. JAMA. 293:836–842. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hui L, Slonim DK, Wick HC, Johnson KL and
Bianchi DW: The amniotic fluid transcriptome: A source of novel
information about human fetal development. Obstet Gynecol.
119:111–118. 2011. View Article : Google Scholar
|
|
8
|
Queloz PA, Crettaz D, Thadikkaran L, Sapin
V, Gallot D, Jani J, Deprest J, Lémery D, Barelli S and Tissot JD:
Proteomic analyses of amniotic fluid: Potential applications in
health and diseases. J Chromatogr B Analyt Technol Biomed Life Sci.
850:336–342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Romero R, Kusanovic JP, Gotsch F, Erez O,
Vaisbuch E, Mazaki-Tovi S, Moser A, Tam S, Leszyk J, Master SR, et
al: Isobaric labeling and tandem mass spectrometry: A novel
approach for profiling and quantifying proteins differentially
expressed in amniotic fluid in preterm labor with and without
intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med.
23:261–280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nicholson JK, Connelly J, Lindon JC and
Holmes E: Metabonomics: A platform for studying drug toxicity and
gene function. Nat Rev Drug Discov. 1:153–161. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roux A, Lison D, Junot C and Heilier JF:
Applications of liquid chromatography coupled to mass
spectrometry-based metabolomics in clinical chemistry and
toxicology: A review. Clin Biochem. 44:119–135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bock JL: Metabolic profiling of amniotic
fluid by proton nuclear magnetic resonance spectroscopy:
Correlation with fetal maturation and other clinical variables.
Clin Chem. 40:56–61. 1994.PubMed/NCBI
|
|
13
|
Graca G, Goodfellow BJ, Barros AS, Diaz S,
Duarte IF, Spagou K, Veselkov K, Want EJ, Lindon JC, Carreira IM,
et al: UPLC-MS metabolic profiling of second trimester amniotic
fluid and maternal urine and comparison with NMR spectral profiling
for the identification of pregnancy disorder biomarkers. Mol
Biosyst. 8:1243–1254. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ivanisevic J, Zhu ZJ, Plate L, Tautenhahn
R, Chen S, O'Brien PJ, Johnson CH, Marletta MA, Patti GJ and
Siuzdak G: Toward ‘omic scale metabolite profiling: A dual
separation-mass spectrometry approach for coverage of lipid and
central carbon metabolism. Anal Chem. 85:6876–6884. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smith CA, Want EJ, O'Maille G, Abagyan R
and Siuzdak G: XCMS: Processing mass spectrometry data for
metabolite profiling using nonlinear peak alignment, matching, and
identification. Anal Chem. 78:779–787. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia J, Sinelnikov IV, Han B and Wishart
DS: MetaboAnalyst 3.0-making metabolomics more meaningful. Nucleic
Acids Res. 43:W251–W257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Graca G, Duarte IF, Barros AS, Goodfellow
BJ, Diaz S, Carreira IM, Couceiro AB, Galhano E and Gil AM: (1)H
NMR based metabonomics of human amniotic fluid for the metabolic
characterization of fetus malformations. J Proteome Res.
8:4144–4150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Graca G, Duarte IF, Barros AS, Goodfellow
BJ, Diaz SO, Pinto J, Carreira IM, Galhano E, Pita C and Gil AM:
Impact of prenatal disorders on the metabolic profile of second
trimester amniotic fluid: A nuclear magnetic resonance metabonomic
study. J Proteome Res. 9:6016–6024. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Field T and Diego M: Cortisol: The culprit
prenatal stress variable. Int J Neurosci. 118:11812008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng JH, Yan YE, Liang G, Liu YS, Li XJ,
Zhang BJ, Chen LB, Yu H, He XH and Wang H: Maternal and fetal
metabonomic alterations in prenatal nicotine exposure-induced rat
intrauterine growth retardation. Mol Cell Endocrinol. 394:59–69.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marcos J, Craig WY, Palomaki GE, Kloza EM,
Haddow JE, Roberson M, Bradley LA and Shackleton CH: Maternal urine
and serum steroid measurements to identify steroid sulfatase
deficiency (STSD) in second trimester pregnancies. Prenat Diagn.
29:771–780. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Trivedi DK and Iles RK: Shotgun
metabolomic profiles in maternal urine identify potential mass
spectral markers of abnormal fetal biochemistry-dihydrouracil and
progesterone in the metabolism of Down syndrome. Biomed Chromatogr.
29:1173–1183. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Menon R, Jones J, Gunst PR, Kacerovsky M,
Fortunato SJ, Saade GR and Basraon S: Amniotic fluid metabolomic
analysis in spontaneous preterm birth. Reprod Sci. 21:791–803.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Herraez E, Lozano E, Poli E, Keitel V, De
Luca D, Williamson C, Marin JJ and Macias RI: Role of macrophages
in bile acid-induced inflammatory response of fetal lung during
maternal cholestasis. J Mol Med (Berl). 92:359–372. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kale E and Kale A: Amniotic fluid amino
acid concentrations in fetal skeletal dysplasia. Clin Exp Obstet
Gynecol. 41:280–282. 2014.PubMed/NCBI
|
|
26
|
Bloomfield FH, van Zijl PL, Bauer MK and
Harding JE: Effects of intrauterine growth restriction and
intraamniotic insulin-like growth factor-I treatment on blood and
amniotic fluid concentrations and on fetal gut uptake of amino
acids in late-gestation ovine fetuses. J Pediatr Gastroenterol
Nutr. 35:287–297. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bednov A, Espinoza J, Betancourt A,
Vedernikov Y, Belfort M and Yallampalli C: L-arginine prevents
hypoxia-induced vasoconstriction in dual-perfused human placental
cotyledons. Placenta. 36:1254–1259. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
da Costa CM, de Freitas MR, Brazão V, dos
Santos CD, Sala MA, do Prado Júnior JC and Abrahão AA: Does
L-arginine availability during the early pregnancy alters the
immune response of Trypanosoma cruzi infected and pregnant Wistar
rats? Exp Parasitol. 142:59–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pimentel AM, Pereira NR, Costa CA, Mann
GE, Cordeiro VS, de Moura RS, Brunini TM, Mendes-Ribeiro AC and
Resende AC: L-arginine-nitric oxide pathway and oxidative stress in
plasma and platelets of patients with pre-eclampsia. Hypertens Res.
36:783–788. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen SF and Hua CH: Effect of L-arginine
on the expression of Bcl-2 and Bax in the placenta of fetal growth
restriction. J Matern Fetal Neonatal Med. 24:822–826. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dudzik D, Revello R, Barbas C and Bartha
JL: LC-MS-based metabolomics identification of novel biomarkers of
chorioamnionitis and its associated perinatal neurological damage.
J Proteome Res. 14:1432–1444. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sakai T: Biomarkers of lead exposure. Ind
Health. 38:127–142. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chou ST, Byrska-Bishop M, Tober JM, Yao Y,
Vandorn D, Opalinska JB, Mills JA, Choi JK, Speck NA, Gadue P, et
al: Trisomy 21-associated defects in human primitive hematopoiesis
revealed through induced pluripotent stem cells. Proc Natl Acad Sci
USA. 109:17573–17578. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chou ST, Opalinska JB, Yao Y, Fernandes
MA, Kalota A, Brooks JS, Choi JK, Gewirtz AM, Danet-Desnoyers GA,
Nemiroff RL and Weiss MJ: Trisomy 21 enhances human fetal
erythro-megakaryocytic development. Blood. 112:4503–4506. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Palmas F, Fattuoni C, Noto A, Barberini L,
Dessi A and Fanos V: The choice of amniotic fluid in metabolomics
for the monitoring of fetus health. Expert Rev Mol Diagn.
16:473–486. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bambrick LL, Yarowsky PJ and Krueger BK:
Glutamate as a hippocampal neuron survival factor: An inherited
defect in the trisomy 16 mouse. Proc Natl Acad Sci USA.
92:9692–9696. 1995; View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Begni B, Brighina L, Fumagalli L, Andreoni
S, Castelli E, Francesconi C, Del Bo R, Bresolin N and Ferrarese C:
Altered glutamate uptake in peripheral tissues from Down syndrome
patients. Neurosci Lett. 343:73–76. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Reynolds GP and Warner CE: Amino acid
neurotransmitter deficits in adult Down's syndrome brain tissue.
Neurosci Lett. 94:224–227. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gregor P, Reeves RH, Jabs EW, Yang X,
Dackowski W, Rochelle JM, Brown RH Jr, Haines JL, O'Hara BF, Uhl
GR, et al: Chromosomal localization of glutamate receptor genes:
Relationship to familial amyotrophic lateral sclerosis and other
neurological disorders of mice and humans. Proc Natl Acad Sci USA.
90:3053–3057. 1993; View Article : Google Scholar : PubMed/NCBI
|
